The Innovation Firm

Gene A. Lang, Ph.D.

Practice Areas

Technologies

Education

  • University of New Hampshire School of Law (formerly the Franklin Pierce Law Center), J.D., Awarded Doris Rapee Endowed Scholarship
  • University of Texas-Houston MD Anderson Cancer Center, Ph.D. in Genes and Development/Cancer Biology, Awarded National Institutes of Health Training Program in Molecular Genetics of Cancer Grant
  • Millsaps College, B.S. in Biology

Professional Associations

  • Intellectual Property Law Association of Florida, President, 2017; Vice-president, 2016; Secretary, 2015
  • Miami-Dade Beacon Council Life Sciences and Healthcare Committee, Member, 2016 – 2018
  • BioFlorida, Member, Leadership Committee- Southeast Chapter, 2015 – 2018
  • Gainesville Area Innovation Network – Stakeholder, 2014-2015

Gene A. Lang, Ph.D.

Gene A. Lang, Ph.D. Attorney

Gene A. Lang, Ph.D.

Associate
Concord office
978.341.0036

For over 10 years, Gene has represented clients in the biotech and pharmaceutical industries in patent prosecution and litigation matters.  Gene counsels domestic and international clients on the preparation, prosecution and management of complex patent portfolios.  He works with clients to obtain patent protection in technical areas such as biotechnology, pharmaceuticals, nanotechnology, clean energy, material sciences and medical devices.  His practice also includes conducting and performing due diligence investigations and preparing patentability, infringement and invalidity opinions.

Recently, Gene worked on patent prosecution matters involving various technologies relating to cancer, diabetes, cardiac and neurodegenerative disease therapies, as well as new chemical compounds useful in modulating hormone levels and treating metabolic disorders.  Gene has also recently handled patent prosecution matters involving use of RNAi technology in agricultural pest control.  

Gene also represents pharmaceutical companies in Hatch-Waxman/Abbreviated New Drug Application (ANDA) litigations.  His experience includes all aspects of fact and expert discovery and pre-trial preparations.  Gene was recently involved in an ANDA litigation involving a multi-billion dollar drug for the treatment of hyperparathyroidism.

Prior to joining the firm, Gene was a pre-doctoral research fellow at the University of Texas-Houston MD Anderson Cancer Center, where he developed mouse models of human cancers and researched mechanisms of cancer metastasis.  His research experience includes cellular and molecular biology, embryonic stem cell manipulation, recombinant DNA techniques, embryology and genomics.  His research is published in several scientific journals, including CellNature Genetics, and Genes & Development.

Scientific Publications

Bar Admissions

  • Florida
  • District of Columbia
  • New Jersey
  • U.S. Patent and Trademark Office
  • United States District Court, Southern District of Florida
  • United States District Court, District of New Jersey
Biography

For over 10 years, Gene has represented clients in the biotech and pharmaceutical industries in patent prosecution and litigation matters.  Gene counsels domestic and international clients on the preparation, prosecution and management of complex patent portfolios.  He works with clients to obtain patent protection in technical areas such as biotechnology, pharmaceuticals, nanotechnology, clean energy, material sciences and medical devices.  His practice also includes conducting and performing due diligence investigations and preparing patentability, infringement and invalidity opinions.

Recently, Gene worked on patent prosecution matters involving various technologies relating to cancer, diabetes, cardiac and neurodegenerative disease therapies, as well as new chemical compounds useful in modulating hormone levels and treating metabolic disorders.  Gene has also recently handled patent prosecution matters involving use of RNAi technology in agricultural pest control.  

Gene also represents pharmaceutical companies in Hatch-Waxman/Abbreviated New Drug Application (ANDA) litigations.  His experience includes all aspects of fact and expert discovery and pre-trial preparations.  Gene was recently involved in an ANDA litigation involving a multi-billion dollar drug for the treatment of hyperparathyroidism.

Prior to joining the firm, Gene was a pre-doctoral research fellow at the University of Texas-Houston MD Anderson Cancer Center, where he developed mouse models of human cancers and researched mechanisms of cancer metastasis.  His research experience includes cellular and molecular biology, embryonic stem cell manipulation, recombinant DNA techniques, embryology and genomics.  His research is published in several scientific journals, including CellNature Genetics, and Genes & Development.

Scientific Publications

Education
  • University of New Hampshire School of Law (formerly the Franklin Pierce Law Center), J.D., Awarded Doris Rapee Endowed Scholarship
  • University of Texas-Houston MD Anderson Cancer Center, Ph.D. in Genes and Development/Cancer Biology, Awarded National Institutes of Health Training Program in Molecular Genetics of Cancer Grant
  • Millsaps College, B.S. in Biology
Professional Associations
  • Intellectual Property Law Association of Florida, President, 2017; Vice-president, 2016; Secretary, 2015
  • Miami-Dade Beacon Council Life Sciences and Healthcare Committee, Member, 2016 – 2018
  • BioFlorida, Member, Leadership Committee- Southeast Chapter, 2015 – 2018
  • Gainesville Area Innovation Network – Stakeholder, 2014-2015
Bar Admissions
  • Florida
  • District of Columbia
  • New Jersey
  • U.S. Patent and Trademark Office
  • United States District Court, Southern District of Florida
  • United States District Court, District of New Jersey

Back to the Top